Michigan specialty veterinary care center seeks dogs for cancer studySeptember 19, 2017 Oakland Veterinary Referral Services (OVRS) specialty veterinary care center is conducting a nationwide study on dogs with canine splenic hemangiosarcoma (HSA) and the benefits of using traditional Chinese herbal medicine (TCHM) as treatment to significantly extend life expectancy. Erin Bannink, DVM, DACVIM, VCHM, CVA, is leading the study, according to Lucy Henney, DVM, DACVS, owner of Bloomfield Hills, Mich.-based OVRS. Most dogs diagnosed with HSA are treated by removal of the spleen after the tumor has ruptured and bled, causing life-threatening blood loss; most dogs living only two months after surgery due to the spread of cancer to other organs, according to Dr. Bannink. Because of HSA's aggressive nature, chemotherapy is usually recommended after surgery in the hope of prolonging life, but it only modestly prolongs survival, and most dogs still die of cancer spread within three to four months of diagnosis, she said. "The purpose of this study is to determine if treatment with a specific herbal therapy regimen is helpful in prolonging survival time after surgery in dogs with HSA and no evidence of cancer spread," said Bannink. "We hypothesize that dogs treated with this standardized protocol after splenectomy will have …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
